retatrutide what is retatrutide clinical trials GLP‑3 Really Is: Triple‑Receptor Drug Retatrutide: What We Know About
Description
Methods Sixteen participants with type 2 diabetes that was relatively well-controlled by metformin monotherapy were studied on four separate days in a crossover design
Studies show neuroprotective effects in Alzheimer's and Parkinson's disease models through reduced inflammation, enhanced neuronal survival, and improved cognitive function
ClinicalTrials.gov number, NCT04122716.
Congrats to IBX EVP and Chief Operating Officer Dr
Erica Oberg offers personalized medical weight loss plans tailored to your needs
For the 9 mg dose, the weight reduction was 26.4%, compared to 2.1% in the placebo group
